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Microbes Battle Back
The bacteria most likely to infect hospital
patients are beginning to display an ability to
resist the antibiotic vancomycin, the last
available line ofdefense in the human battle
against such microbes. Many Staphylococcus
aureus strains have already developed resis-
tance to commonly used antibiotics such as
penicillin and methicillin, and for
nearly two decades vancomycin
has been the only certain
way to thwart an S. aureus
infection. Now it seems
that the microbe is
adapting resistance to
vancomycin, which
may leave only experi-
mental new antibiotics
to stop a public health
crisis.
The new super-resilient
strain of the bacterium was
discovered in May 1996 at the Staphylococc
Juntendo University hospital in
Tokyo, where it had infected a 4-month-old
boy recovering from heart surgery. Japanese
health officials reported the finding in May
1997 and provided an isolate ofthe bacteri-
um to the U.S. Centers for Disease Control
and Prevention, which confirmed the resis-
tance profile, reporting in the 11 July 1997
issue of Morbidity and Mortality Weekly
Report that the bacterium exhibited low-
level resistance to vancomycin. "Clinically,
it showed decreased susceptibility. . . It
was not completely resistant to van-
comycin," explains Michael Edmond, a hos-
pital epidemiologist at the Medical College
ofVirginia in Richmond. "That means that
the clinical outcome will depend on the site
of the infection. How effective the treat-
ment is really depends on how much van-
comycin can be introduced into that area.
In this case . . . the child had a wound
infection, which is a case where enough
vancomycin can be used to eliminate the
infection. An infection in a place like the
cerebral spinal fluid would be particularly
hard to treat."
S. aureus infections ofthe cerebral spinal
fluid are not common, but the discovery of
this newstrain hints that strains that arefully
resistant to vancomycin and that could not
be effectively treated in any location are
emerging. Their emergence could give rise to
a situation similar to that before the advent
of antibiotics-when S. aureus was an
extremely deadlygerm.
S. aureus is commonly found on the skin
and can live harmlessly in the nasal passages
and pudendum. But, when the bacteria over-
grow, enter the bloodstream, or produce a
toxin, they can cause skin pustules, toxic
shock syndrome, blood stream infec-
tions, pneumonia, and death.
Because it is so prevalent, S.
aureusis also the most com-
mon cause of surgical-site
infections in hospitals.
This makes the develop-
ment of a completely
antibiotic-resistant strain
particularly worrisome
for public health workers.
M ; l, And, says Edmond, "Ifwe
can't control it in the hospi-
tals, it could easily spread out
usaureus into thecommunity."
Antibiotic resistance rises from
genetic changes in the bacterium that either
make it impenetrable by the antibiotic or
that allow it to produce a chemical that
reacts with the antibiotic, rendering the
antibiotic harmless. Once one bacterium has
developed such a resistance, it can be passed
on to other bacteria either by transformation
(a form ofgenetic recombination resulting in
an exchange of DNA between microbes) or
through plasmids (specialized rings of DNA
that travel from microbe to microbe).
Plasmids have been known to carrythe infor-
mation for resistance to four different antibi-
otics at once.
Hospital personnel may also be con-
tributing to the likelihood that resistant S.
aureusstrains will develop and flourish. "The
problem is that vancomycin is commonly
used in hospitals, and it may have been
overused," Edmond says. If the antibiotic is
used on an infection where only a few ofthe
bacteria are resistant to it, all but the van-
comycin-resistant strain will die, leaving that
strain to grow and reproduce with little com-
petition. S. aureus is also a hardy bacterium
that can survive outside of the body for
weeks and travel considerable distances
through the air, making itvery easy to spread
the infection.
Edmond was one ofmany health profes-
sionals who predicted the advent of van-
comycin-resistant S. aureus. The bacterium
has been efficient in defeating other antibi-
otics. For example, it developed resistance to
penicillin in 1947, just four years after drug
companies had begun mass-producing the
medicine. Other common bacteria, including
enterococcus, a common parasite in the
human gut, have already developed van-
comycin-resistant strains, and it seemed only
a matter of time before this resistance was
passed on to S. aureus. In 1992, a British
researcher observed such a transfer take place
in the laboratory, but until this year, no van-
comycin-resistant S. aureus had been
observed in thewild.
TheJapanese doctors who discovered the
resistant strain vigorously treated the infec-
tion with vancomycin, the antibiotic ampi-
cillin/sulbactum, and arbekacin, an amino-
glycoside approved for use against methi-
cillin-resistant S. aureus in Japan but not in
the United States. The organism tested nega-
tive for the genes responsible for vancomycin
resistance in enterococci; the mechanism by
which this strain was able to withstand van-
comycin is still under investigation.
Secondhand Smoke and
Heart Disease
Womenwho have never smoked butwho are
regularly exposed to cigarette smoke at home
or atwork are almost twice as likely to devel-
op coronary heart disease as women who are
not exposed to tobacco smoke, according to
astudy in the 20 May 1997 issue ofthejour-
nal Circulation. This latest study is another
black eye for the already embattled tobacco
industry and new ammunition for individu-
als claiming that they have been unfairly
harmed by so-called secondhand tobacco
smoke.
Over a dozen studies have been under-
taken to assess the relationship between envi-
ronmental tobacco smoke and coronaryheart
disease, but this is the strongest association
yet observed. Other studies have found that
nonsmokers exposed to environmental
tobacco smoke increase their risk ofcoronary
heart disease by 20-30%, although some
studies have not been able to find any statis-
tically significant excess risk associated with
exposure to environmental tobacco smoke.
The authors of the latest study contend,
however, that their research improves upon
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